The Anti-Malignin in Antibody in Serum (AMAS) test is a reliable, sensitive blood test for cancerous growth in the body. Blood is taken at a nearby lab and sent overnight to a lab in Boston, MA. Results aregenerally received within a week.

The AMAS test willl accurately detect early cancer of all types. It has an accuracy rate of greater than 95%. If the test is repeated, the accuracy is greater than 99% (false positive and false negative rates are less than 1%).

Twenty-one years ago a neurochemist, Samuel Bogoch, MD, PhD, discovered a test for cancer antigen, similar to today's Prostate Specific Antigen (PSA) for prostate cancer and CEA for colorectal cancer. With hard work and good sound research, he found the first anticancer antibody in the bloodstream of patients with cancer. He named the new antigen malignin, and called the new antibody Anit-Malignin Antibody. He founded a laboratory in Boston called Oncolab, Inc. The test has finally been patented and the FDA has granted permission to market this test.

 

The AMAS test willl accurately detect early cancer of all types.